Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2018 5
2019 1
2020 3
2021 3
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
A Narrative Review on Therapeutic Potentials of Watercress in Human Disorders.
Panahi Kokhdan E, Khodabandehloo H, Ghahremani H, Doustimotlagh AH. Panahi Kokhdan E, et al. Among authors: khodabandehloo h. Evid Based Complement Alternat Med. 2021 May 7;2021:5516450. doi: 10.1155/2021/5516450. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34055006 Free PMC article. Review.
Nanocarriers Usage for Drug Delivery in Cancer Therapy.
Khodabandehloo H, Zahednasab H, Ashrafi Hafez A. Khodabandehloo H, et al. Iran J Cancer Prev. 2016 Apr 24;9(2):e3966. doi: 10.17795/ijcp-3966. eCollection 2016 Apr. Iran J Cancer Prev. 2016. PMID: 27482328 Free PMC article. Review.
Empagliflozin induces apoptotic-signaling pathway in embryonic vasculature: In vivo and in silico approaches via chick's yolk sac membrane model.
Mosallanejad S, Mahmoodi M, Tavakkoli H, Khosravi A, Salarkia E, Keyhani A, Dabiri S, Gozashti MH, Pardakhty A, Khodabandehloo H, Pourghadamyari H. Mosallanejad S, et al. Among authors: khodabandehloo h. Front Pharmacol. 2022 Sep 1;13:970402. doi: 10.3389/fphar.2022.970402. eCollection 2022. Front Pharmacol. 2022. PMID: 36120349 Free PMC article.
The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial.
Gohari S, Reshadmanesh T, Khodabandehloo H, Karbalaee-Hasani A, Ahangar H, Arsang-Jang S, Ismail-Beigi F, Dadashi M, Ghanbari S, Taheri H, Fathi M, Muhammadi MJ, Mahmoodian R, Asgari A, Tayaranian M, Moharrami M, Mahjani M, Ghobadian B, Chiti H, Gohari S. Gohari S, et al. Among authors: khodabandehloo h. Diabetol Metab Syndr. 2022 Nov 17;14(1):170. doi: 10.1186/s13098-022-00951-5. Diabetol Metab Syndr. 2022. PMID: 36397128 Free PMC article.
Study rationale and design of a study of EMPAgliflozin's effects in patients with type 2 diabetes mellitus and Coronary ARtery disease: the EMPA-CARD randomized controlled trial.
Gohari S, Reshadmanesh T, Khodabandehloo H, Fathi M, Ahangar H, Arsang-Jang S, Ismail-Beigi F, Ghanbari S, Dadashi M, Muhammadi MJ, Gohari S, Ghaffari S. Gohari S, et al. Among authors: khodabandehloo h. BMC Cardiovasc Disord. 2021 Jun 30;21(1):318. doi: 10.1186/s12872-021-02131-1. BMC Cardiovasc Disord. 2021. PMID: 34193056 Free PMC article.
Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Karbalaee-Hasani A, Khadive T, Eskandari M, Shahidi S, Mosavi M, Nejadebrahimi Z, Khalkhali L, Sangdari A, Mohammadi D, Soltani A, Khodabandehloo H, Hosseini H, Koushki M. Karbalaee-Hasani A, et al. Among authors: khodabandehloo h. Ann Pharmacother. 2021 Sep;55(9):1096-1109. doi: 10.1177/1060028020985303. Epub 2021 Jan 7. Ann Pharmacother. 2021. PMID: 33412927
17 results